<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">10468297</article-id><article-id pub-id-type="pmc">2363132</article-id><article-id pub-id-type="pii">6690598</article-id><article-id pub-id-type="doi">10.1038/sj.bjc.6690598</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Phase I and pharmacokinetic study of DACA (XR5000): a novel inhibitor of topoisomerase I and II</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Twelves</surname><given-names>C J</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Gardner</surname><given-names>C</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Flavin</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Sludden</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Dennis</surname><given-names>I</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Bono</surname><given-names>J de</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Beale</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Vasey</surname><given-names>P</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hutchison</surname><given-names>C</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Macham</surname><given-names>M A</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Judson</surname><given-names>I</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Bleehen</surname><given-names>N M</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib></contrib-group><aff id="aff1"><label>1</label>CRC Department of Medical Oncology, Alexander Stone Building, Glasgow, Bearsden, G61 1BD, UK</aff><aff id="aff2"><label>2</label>Data Centre, Cancer Research Campaign, 10 Cambridge Terrace, London, NW1 4JL, UK</aff><aff id="aff3"><label>3</label>MRC Clinical Oncology and Radiotherapy Unit, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK</aff><aff id="aff4"><label>4</label>Royal Marsden Hospital, Institute of Cancer Research, Drug Development Section, Block E, 15 Cotswold Road, Sutton, Surrey, SM2 5NG, UK</aff><pub-date pub-type="ppub"><month>08</month><year>1999</year></pub-date><volume>80</volume><issue>11</issue><fpage>1786</fpage><lpage>1791</lpage><history><date date-type="received"><day>30</day><month>07</month><year>1998</year></date><date date-type="rev-recd"><day>19</day><month>01</month><year>1999</year></date><date date-type="accepted"><day>20</day><month>02</month><year>1999</year></date></history><copyright-statement>Copyright 1999, Cancer Research Campaign</copyright-statement><copyright-year>1999</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><kwd-group><kwd>phase I</kwd><kwd>cytotoxic</kwd><kwd>pharmacokinetics</kwd><kwd>topoisomerase I</kwd><kwd>topoisomerase II</kwd></kwd-group></article-meta></front></article>


